Proteome Sciences plc provided revenue guidance for 2013. For the year, revenue expected to show a significant increase over 2012 resulting from the strong performance across core activities.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.21 GBX | 0.00% |
|
0.00% | -7.06% |
May. 16 | Proteome Sciences promises AGM return to growth in 2024 | AN |
May. 16 | AIM WINNERS & LOSERS: Proteome Sciences eyes return to growth in 2024 | AN |
1st Jan change | Capi. | |
---|---|---|
-7.06% | 15.76M | |
-5.81% | 180B | |
-1.63% | 106B | |
-4.14% | 67.55B | |
-6.56% | 46.11B | |
+13.22% | 45.79B | |
+6.13% | 41.61B | |
+19.93% | 31.07B | |
+13.61% | 24.77B | |
-5.36% | 24.27B |
- Stock Market
- Equities
- PRM Stock
- News Proteome Sciences plc
- Proteome Sciences plc Provides Revenue Guidance for 2013